Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-04T20:28:48.210Z Has data issue: false hasContentIssue false

Increased erythrocyte inositol monophosphatase activity in schizophrenia

Published online by Cambridge University Press:  16 April 2020

JK Rybakowski
Affiliation:
Department of Adult Psychiatry, University of Medical Sciences, ul Szpitalna 27/33, 60-572Poznan
W Lehmann
Affiliation:
Department of Psychiatry, Medical Academy, 85-096Bydgoszcz, Poland

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the editor
Copyright
Copyright © Elsevier, Paris 1997

References

Hallcher, LM, Sherman, WR. The effect of lithium ion and other agents on the activity of inositol-1-phosphatase from bovine brain. J Biol Chem 1980; 255: 1089610901Google Scholar
Mikuni, M, Kusumi, I, Kagaya, A, Kuroda, Y, Mori, H, Takahashi, K. Increased 5-HT-2 receptor function as measured by serotonin-stimulated phosphoinositide hydrolysis in platelets of depressed patients. Prog Neuro-Psychopharmacol Biol Psychiatry 1991; 15: 4961Google ScholarPubMed
Ripova, D, Nemcova, V, Strunecka, A, Höschl, C. Insositol lipid signalling system in schizophrenia Homeostasis 36Suppl 11995 126Google Scholar
Williams, J, Spurlock, G, McGuffin, P, et al.Association between schizophrenia and T102C polymorphism of the 5-hydroxy-tryptamine type 2a-receptor gene. Lancet 1996; 347: 1294129610.1016/S0140-6736(96)90939-3CrossRefGoogle ScholarPubMed
Zilberman-Kaufman, M, Agam, G, Moscovitz, L, Livne, AA, Belmaker, RH. Elevated inositol monophosphatase activity in schizophrenic patients. Clin Chim Acta 1992; 209: 8993CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.